Hormone Receptor Negative Tumor clinical trials at UCSF
1 research study open to eligible people
Hormone Receptor Negative Tumors are a type of breast cancer that do not respond to hormone therapy. UCSF is currently recruiting for a clinical trial called "I-SPY TRIAL" that aims to discover which new drug agents are most effective in treating this type of tumor. The trial is focused on personalized medicine and testing novel treatments.
open to eligible people ages 18 years and up
The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.
San Francisco, California and other locations